Company Filing History:
1 out of 117 
1 out of 8 Years Active: 2020
Title: Innovations of Jinxiang Chen in Magnetic Resonance Imaging
Introduction
Jinxiang Chen is a notable inventor based in Taipa, Macau. He has made significant contributions to the field of medical imaging, particularly through his innovative work on contrast agents for magnetic resonance imaging (MRI). His research focuses on enhancing the properties of these agents to improve imaging techniques.
Latest Patents
Jinxiang Chen holds a patent for a "Crystalline contrast agent for magnetic resonance imaging, kit and composition comprising it and their use." This invention details a method for preparing a crystalline contrast agent using a zwitterionic carboxylic pyridyl ligand. The process involves mixing a metal ion with the pyridyl ligand to obtain crystals. The resulting crystalline contrast agent features a manganese-organic or gadolinium-organic 3D framework. This agent is utilized in a kit and a pharmaceutically acceptable composition. The method allows for the creation of crystalline contrast agents with superior properties, utilizing readily available starting materials in an economical and efficient manner. These agents exhibit exceptional water-stability and water-solubility, high longitudinal relaxivities, and excellent stability under physiological conditions with low cytotoxicity. Additionally, the invention includes a method for in vivo imaging of subjects, particularly humans, by administering the crystalline contrast agent.
Career Highlights
Jinxiang Chen has worked at prominent institutions such as the Macau University of Science and Technology and Southern Medical University. His experience in these organizations has contributed to his expertise in the field of medical imaging and contrast agents.
Collaborations
Jinxiang Chen has collaborated with notable colleagues, including Jianxin Pang and Shuwen Liu. Their joint efforts have further advanced research in the area of MRI contrast agents.
Conclusion
Jinxiang Chen's innovative work in developing crystalline contrast agents for magnetic resonance imaging represents a significant advancement in medical imaging technology. His contributions have the potential to enhance diagnostic capabilities and improve patient outcomes.